Muir Glenn P
- SEC CIK
- 0001181190
No open-market purchases or sales filed in the past year.
Current role at each company
- CTKB Cytek Biosciences, Inc.Directoras of Aug 20, 2026
- STIM Neuronetics, Inc.Directoras of May 29, 2026
- RGEN Repligen CorpDirectoras of May 18, 2026
- GTHX G1 Therapeutics, Inc.Directoras of Sep 18, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Muir Glenn P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
STIM Neuronetics, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 6, 2024 (view filing) | Sep 5 | 1 day | Muir Glenn PDirector | PPurchase | +25.0K | $0.80 | +$20.0K | +9.4%289.8K after | |
| Aug 30, 2024 (view filing) | Aug 28-29 | 2 days | Muir Glenn PDirector | PPurchase | +25.0K | $0.85 | +$21.3K | +10.4%264.8K after | 2 lots |
| Aug 21, 2024 (view filing) | Aug 20 | 1 day | Muir Glenn PDirector | PPurchase | +25.0K | $1.00 | +$25.0K | +11.6%239.8K after | |
| Aug 16, 2024 (view filing) | Aug 14 | 2 days | Muir Glenn PDirector | PPurchase | +25.2K | $0.75 | +$18.9K | +13.3%214.8K after |